Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome

被引:5
作者
Ji, Ying [1 ]
Wang, Yan-Li [2 ]
Xu, Fang [1 ]
Jia, Xi-Bei [1 ]
Mu, Su-Hong [1 ]
Lyu, Hui-Yan [1 ]
Yuan, Xue-Ying [1 ]
Na, Shi-Ping [1 ]
Bao, Yu-Shi [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Nephrol, 23 Youzheng St, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Rheumatol, Harbin, Peoples R China
关键词
podoplanin; C-type lectin-like receptor 2; nephrotic syndrome; hypercoagulable state; thrombosis; VENOUS THROMBOSIS; TUMOR-METASTASIS; RECEPTOR CLEC-2; THROMBOEMBOLISM; PLATELETS; INTEGRITY; ROLES; MICE;
D O I
10.1177/10760296221108967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Podoplanin (PDPN) promotes platelet aggregation and activation by interacting with C-type lectin-like receptor 2(CLEC-2) on platelets. The interaction between the upregulated PDPN and platelet CLEC-2 stimulates venous thrombosis. PDPN was identified as a risk factor for coagulation and thrombosis in inflammatory processes. Hypercoagulability is defined as the tendency to develop thrombosis according to fibrinogen and/or D dimer levels. Nephrotic syndrome is also considered to be a hypercoagulable state. The aim of this study is to investigate the association of soluble PDPN/CLEC-2 with hypercoagulability in nephrotic syndrome. Thirty-five patients with nephrotic syndrome and twenty-seven healthy volunteers were enrolled. PDPN, CLEC-2 and GPVI concentrations were tested by enzyme-linked immunosorbent assay (ELISA). Patients with nephrotic syndrome showed higher serum levels of PDPN and GPVI in comparison to healthy controls (P < .001, P = .001). PDPN levels in patients with nephrotic syndrome were significantly correlated with GPVI (r = 0.311; P = .025), hypoalbuminemia (r = -0.735; P < .001), hypercholesterolemia (r = 0.665; P < .001), hypertriglyceridemia (r = 0.618; P < .001), fibrinogen (r = 0.606; P < .001) and D-dimer (r = 0.524; P < .001). Area under the curve (AUC) for the prediction of hypercoagulability in nephrotic syndrome using PDPN was 0.886 (95% CI 0.804-0.967, P < .001). Cut-off value for the risk probability was 5.88 ng/ml. The sensitivity of PDPN in predicting hypercoagulability was 0.806, and the specificity was 0.846. When serum PDPN was >5.88 ng/ml, the risk of hypercoagulability was significantly increased in nephrotic syndrome (OR = 22.79, 95% CI 5.92-87.69, P < .001). In conclusion, soluble PDPN levels were correlated with hypercoagulability in nephrotic syndrome. PDPN has the better predictive value of hypercoagulability in nephrotic syndrome as well as was a reliable indicator of hypercoagulable state.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] CEREBRAL INFARCTION IN PATIENTS WITH NEPHROTIC SYNDROME
    MARSH, EE
    BILLER, J
    ADAMS, HP
    KAPLAN, JM
    STROKE, 1991, 22 (01) : 90 - 93
  • [22] Free flaps in nephrotic syndrome patients
    Al-Thunayyan, A.
    Al-Dekhayet, S. A.
    Al-Namla, A.
    Al-Qattan, Mohammad M.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2009, 62 (04) : 555 - 556
  • [23] Medication Adherence in Patients with Nephrotic Syndrome
    Setyawati, Amallia Nuggetsiana
    Mellyana, Omega
    Muryawan, M. Heru
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (01): : 411 - 414
  • [24] Characterization of thromboelastography of patients with different pathological types of nephrotic syndrome
    Lu, Chunlei
    Zuo, Ke
    Le, Weibo
    Chen, Wencui
    Qin, Weisong
    Zhang, Fan
    Liang, Shaoshan
    Zeng, Caihong
    Wang, Jinquan
    MEDICINE, 2020, 99 (05)
  • [25] LIPOPROTEIN(A) LEVELS AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH NEPHROTIC SYNDROME
    HONG, SY
    YANG, DH
    NEPHRON, 1995, 69 (02): : 125 - 130
  • [26] Expression pattern of aquaporins in patients with primary nephrotic syndrome with edema
    Wang, Yu
    Bu, Jimei
    Zhang, Qing
    Chen, Kai
    Zhang, Jihong
    Bao, Xiaorong
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 5625 - 5632
  • [27] Elevated serum CA-125 levels in a patient with nephrotic syndrome
    Orlowska-Kowalik, Grazyna
    Malecka-Massalska, Teresa
    Ksiazek, Andrzej
    AMERICAN JOURNAL OF CASE REPORTS, 2008, 9 : 351 - 354
  • [28] Elevated Levels of Urinary Podocyte-Derived Microparticles in Nephrotic Syndrome
    Hidayati, Eka Laksmi
    Supriyatno, Bambang
    Pardede, Sudung Oloan
    Trihono, Partini Pudjiastuti
    Sukmawati, Dewi
    Wulandari, Dewi
    Ramayani, Oke Rina
    INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (05): : 328 - 335
  • [29] Elevated interleukin-18 levels in the urine of nephrotic patients
    Matsumoto, K
    Kanmatsuse, K
    NEPHRON, 2001, 88 (04): : 334 - 339
  • [30] Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome
    Ismail, Gener
    Obrisca, Bogdan
    Jurubita, Roxana
    Andronesi, Andreea
    Sorohan, Bogdan
    Harza, Mihai
    MEDICINA-LITHUANIA, 2020, 56 (05):